According to the NIH, the PI is ultimately responsible for certifying that all Other Support is included by electronically signing the document. The NIH mandatory certification text for Investigators is as follows:

I, _________________, senior/key personnel, certify that the statements herein are true, complete, and accurate to the best of my knowledge, and accept the obligation to comply with Public Health Services terms and conditions if a grant is awarded as a result of this application.  I am aware that any false, fictitious, or fraudulent statements or claims may subject me to criminal, civil, or administrative penalties.

Other Support includes but is not limited to:

• IN-KIND contributions, e.g. office/laboratory space, equipment, supplies, or employees or students supported by an outside source. If the in-kind contribution's time commitment or dollar value is not readily ascertainable, the recipient must provide reasonable estimates in the IN-KIND section.

• All active NIH awards require a measurable effort for the named PI/Key Personnel and all pending NIH awards should have an effort level. If senior/key personnel will have an overlap; A detailed overlap statement needs to be provided with effort adjustments to address any potential over-commitment.   

• Immediate notification of undisclosed Other Support. When a recipient’s organization discovers that a PI or other Senior/Key personnel on an active NIH grant failed to disclose Other Support information outside of Just-in-Time or the RPPR, as applicable, the recipient must submit updated Other Support to the Grants Management Specialist named in the Notice of Award as soon as it becomes known.

All senior/key personnel, excluding consultants, must report when there has been a change in an active or pending grant in their other support.

For more information visit: https://grants.nih.gov/grants/forms/othersupport.htm;

See NOT-OD-21-073 / NOT-OD-21-110 for specific changes and details). or contact Pre-Award.

.

Access Matchmaker by clicking on the link: https://reporter.nih.gov/matchmaker or contact Pre Award.  

.

The new California Experimental Subject Bill of Rights template no longer requires a signature.

The PHI Authorization template no longer requires a PI signature.

Please note, if still using templates with a signature space indicated, the signature must still be obtained. The LLUH IRB encourages the use of the most updated forms on the website. The new templates may be found at:   https://researchaffairs.llu.edu/research-compliance/human-studies/irb-toolkit

.

• Letters of Intent must be submitted no later than

                Monday, August 7, 2023 - 5:00 PM

• New application due date

                Monday, Sept 18, 2023 - 5:00 PM

The Office of the Dean of the School of Medicine is pleased to request Research Proposals for the 2024 Grants for Collaborative and Translational Research (GCAT) program.

GCAT Instructions

PHASE I – $75,000 Award per Proposal

Goal: To gather the preliminary data needed to compete for a Foundation, R03 or R21 grant (or equivalent)

Eligibility: Physician Scientist Teams

PHASE II - $100,000 Award per Proposal

Goal: To leverage and extend results from Phase I to develop and submit a competitive application for R01 (or equivalent) funding

Eligibility: Physician Scientist Teamswho have successfully completed Phase I

All types of research within the mission of the School of Medicine will be considered, with a project period of no more than two years. Instructions for proposals can be found in the GCAT RFA and at this link: https://medicine.llu.edu/research/upcoming-events-and-announcements/grants-promote-collaborative-and-translational-research

More information is available on the GCAT webpage, the Pre Award office at X55160, or Penelope Duerksen-Hughes (pdhughes@llu.edu).